Omega Diagnostics Group (ODX)

 

ODX Share PerformanceMore

52 week high28.01 25/05/17
52 week low15.75 11/10/16
52 week change 5.00 (32.26%)
4 week volume2,355,999 31/05/17

Media for (ODX)

Presenter: Kieron Harbinson, Group Finance Director
07/07/2015
Presenter: Kieron Harbinson, Group Finance Director
15/04/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Omega Diagnostics sees FY adj. pretax profit at £1.1m

Omega Diagnostics says its FY results will be in line with market views, with revenues seen at 14.3m and adjusted profit be...

Trading Update and Notice of Results

RNS Number: 1774D Omega Diagnostics Group PLC 25 April 2017 Omega Diagnostics Group PLC ("Omega" or "the Company") Trading Update and Notice of Results Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that results for the year to 31 March 2017 will be in line with market expec...

Holding(s) in Company

RNS Number: 0156D Omega Diagnostics Group PLC 21 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Omega Diagnostics Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of votin...

VISITECT? Malaria CE-Mark & Indian FDA inspection

RNS Number: 8169A Omega Diagnostics Group PLC 29 March 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") VISITECT Malaria CE-Mark and successful Indian FDA inspection Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked its VISITECT range o...

Holding(s) in Company

RNS Number: 7239Y Omega Diagnostics Group PLC 07 March 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Omega Diagnostics Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of vot...

Holding(s) in Company

RNS Number: 9524X Omega Diagnostics Group PLC 27 February 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Omega Diagnostics Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of ...

Omega Diagnostics update on talks with IDS

Omega Diagnostics says, following talks, that Immunodiagnostic Systems Holdings confirms its preferred course of action ...

Update on discussions with IDS

RNS Number: 2449V Omega Diagnostics Group PLC 27 January 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") Update on discussions with Immunodiagnostic Systems Holdings plc Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces the following update on its discussions wi...

Fundamental DataMore

P/E ratio41
EPS0.5
Dividend yield0 %

Equity Research (ODX)

hardman & co
Omega Diagnostics Group PLC
02/05/2017
Omega Diagnostics Group has an established core business providing high quality in vitro diagnostic tests within three core areas of competence – Food Intolerance, Allergy & Autoimmune,...
hardman & co
Omega Diagnostics Group PLC
29/11/2016
Omega Diagnostics Group has an established core business providing high quality in vitro diagnostic tests within three core areas of competence – Food Intolerance, Allergy & Autoimmune,...
edison investment research
Omega Diagnostics Group PLC
05/04/2016
Edison Investment Research is terminating coverage on Omega Diagnostics Group plc (ODX). Please note you should no longer rely on any previous research or estimates for this company. All forecasts...

Latest discussion posts More

  • why haven't Finncap got a 20p target price ?

    Finncap do not appear to have changed their price on this I wonder why ?
    18-Jun-2017
    biswell2
  • New 3-year highs today

    ODX has a highly profitable and growing core business supported by a number of "blue sky" opportunities which are now at or approaching commercialisation.
    31-May-2017
    gretel
  • New web site

    ODX have a new web site - presumably a new broom to capitalise on the transformational developments going on at present: Http://www.omegadiagnostics.com/
    8-May-2017
    gretel

Users' HoldingsMore

Users who hold Omega Diagnostics Group also hold..
LLOYDS GRP.35%
SAINSBURY(J)22%
CENTRICA19%
BP19%
ROYAL BANK SCOT19%

Codes & Symbols

ISINGB00B1VCP282
SymbolsODX, LSE:ODX, ODX.L, ODX:LN, LON:ODX, XLON:ODX